416 related articles for article (PubMed ID: 18636157)
1. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic analysis of the ribosomes in 5-fluorouracil resistance of a human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
Kimura K; Wada A; Ueta M; Ogata A; Tanaka S; Sakai A; Yoshida H; Fushitani H; Miyamoto A; Fukushima M; Uchiumi T; Tanigawa N
Int J Oncol; 2010 Nov; 37(5):1271-8. PubMed ID: 20878074
[TBL] [Abstract][Full Text] [Related]
3. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
5. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
[TBL] [Abstract][Full Text] [Related]
6. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
7. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
9. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
Yoshida K; Kuramitsu Y; Murakami K; Ryozawa S; Taba K; Kaino S; Zhang X; Sakaida I; Nakamura K
Anticancer Res; 2011 Jun; 31(6):2103-8. PubMed ID: 21737628
[TBL] [Abstract][Full Text] [Related]
10. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
[TBL] [Abstract][Full Text] [Related]
11. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
[TBL] [Abstract][Full Text] [Related]
15. [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].
Wang Y; Cao J; Zeng S
Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):342-6. PubMed ID: 14724945
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis for the identification of proteins related to methotrexate resistance.
Feng YX; Bai J; Zhang CY; Fu SB
Yi Chuan Xue Bao; 2006 May; 33(5):391-6. PubMed ID: 16722333
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
Dai Z; Yin J; He H; Li W; Hou C; Qian X; Mao N; Pan L
Proteomics; 2010 Nov; 10(21):3789-99. PubMed ID: 20957754
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study on human colonic-cancer cell line, DLD-1 and the 5-FU resistant cell line].
Ito R
Hokkaido Igaku Zasshi; 2004 Jul; 79(4):413-25. PubMed ID: 15373213
[No Abstract] [Full Text] [Related]
20. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
